Our Experts

We Engineer Breakthrough Value

Lumanity brings together a unique and diverse team of 1200 deeply experienced industry pioneers, data luminaries, subject matter experts, and proven problem-solvers. Meet the experts that deliver breakthrough value and help accelerate access to the treatments that transform lives.

Our Experts

Amit Ahuja MPharm, LLB Senior Director, Research, HEOR
Read more about Amit Ahuja
Headshot of James Aird
James Aird Principal, Strategy Consulting
Read more about James Aird
Ron Akehurst BSc, DSc, MFPH Chairman, HEOR
Read more about Ron Akehurst
Headshot of Bronwen Andrews
Bronwen Andrews Senior Director, HEOR Global Commercial Partnerships
Read more about Bronwen Andrews
Jane Ayton Senior Vice President, Strategic Client Partnerships
Read more about Jane Ayton
Siobhan Barry Vice President, Client Strategy, Patient Engagement
Read more about Siobhan Barry
Sam Barnes
Sam Barnes Senior Vice President, Growth Strategy
Read more about Sam Barnes
Kevin Baruzzi Senior Vice President, Strategy Consulting
Read more about Kevin Baruzzi
Whitepaper Approval is a Milestone, Access is the Mission
FDA approval alone is no longer sufficient for biopharma success in 2026. Companies must integrate regulatory, clinical, HEOR/RWE, and market access strategy from early development—rather than treating them as sequential handoffs—in order to close the widening gap between FDA approval and real-world market access created by IRA Medicare price negotiation, the EU's Joint Clinical Assessment framework, and unpredictable FDA advisory committee outcomes.
Sep 29, 2026 Katie McCarthy SVP and Practice Lead, Clinical & Regulatory Services
Read more about Approval is a Milestone, Access is the Mission